Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-009710

Options or other derivatives

  • President, CEO acquired 448,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SANDS ARTHUR T President, CEO 2023-02-14 Grant or award · Employee Stock Option (right to buy) +448,000 448,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…